Awards and Nominations
With over 30 years of brand and product development experience in the nutraceutical, pharmaceutical, and medical device sectors, Edalat founded Vivera with the mission of prioritizing patients over profits.
His forward-thinking management approach as CEO has seen Vivera grow from a single division at its founding to over five divisions, all striving to enhance patient care and address diverse medical needs. Leading Vivera’s business development domestically and internationally, Edalat works closely with Vivera’s sales and marketing teams to anticipate and meet market demands. With trusted global relationships built over the decades, Edalat has worked to leverage his connections and expand Vivera’s reach. In addition, he has led the company through innovative research and development at home.
Edalat’s dedication to his mission has not gone unnoticed. His remarkable leadership and growth led to his selection as a member of the esteemed Forbes Council, an honor reserved for outstanding individuals who’ve demonstrated exceptional entrepreneurial expertise and insight.
Other industry experts and notable publications have also taken notice of Edalat’s impact. LA Times B2B Publishing selected Edalat as a CEO Visionary nominee two years in a row. The Orange County Business Journal further acknowledged Edalat’s remarkable influence and visionary approach through honorable nominations for the Excellence in Entrepreneurship and the Innovator of the Year Awards.
Edalat’s innovation-driven pursuit has also landed him a spot on LA Weekly’s Top 10 Inspiring Innovators Pushing the Boundaries in Their Industries.
Other considerable recognitions underscoring his commitment to innovation and excellence include:
• Most Influential Business Leaders To Watch In 2023 -The Enterprise World
• Top 5 Entrepreneurs to Watch in 2024 – USA Today
• BizBoard CEOs to Watch in 2023 – Aspioneer
• World’s Most Inspiring CEOs to Watch in 2023 – World’s Leaders
• The 10 Most Successful Business Leaders Making a Difference in 2023 – Inc. Magazine
• Top 5 Impactful Healthcare Leaders to Watch in 2023 – Insights Care
• 10 Most Inspiring Business Leaders to Follow in 2023 – CIO Views
• The 10 Most Admired Leaders in Pharmaceuticals in 2023 – CIO Look
• 10 Most Prominent Business Leaders to Follow in 2023 – Tycoon Success
• 10 Most Impactful Business Leaders to Follow in 2023 – Insights Success
Authored Articles
MedTech Outlook: Top 10 Drug Delivery Solution Providers Paul Edalat discusses the future of ZICOH, a patented, high-tech, smart, dose-controlled prescription medication delivery system that works seamlessly through the medication supply chain from the manufacturer to the patient to provide a fully integrated solution to prescription drug abuse.
ONdrugDELIVERY: Smart Drug Delivery Devices Improve Medication Adherence: Here’s How Paul Edalat, Chairman, Founder & Chief Executive Officer, and Mehdi Hatamian, PhD, Senior Scientific Advisor & Interim Chief Scientific Officer, both at Vivera Pharmaceuticals, take an in-depth look at medication non-adherence and how technology can be used to improve compliance rates and optimize patient outcomes.
ZICOH Patents
ZICOH is a smart prescription drug delivery device that integrates seamlessly with ZICOH Connect™, a cloud-based software system that harnesses the power of artificial intelligence to optimize patient outcomes. This comprehensive system seeks to enhance patient compliance and deter diversion, with the goal of ultimately reducing the risk of addiction associated with certain habit-forming medications.
The U.K. Intellectual Property Office (IPO) grants Vivera’s ZICOH device patent, securing its rights as a Smart Inhaler Device with Automated Dose Delivery, Measurement, and Management.
The U.S. Patent and Trademark Office (USPTO) grants a third U.S. Patent for ZICOH, securing its rights as a Secure Smart Dosing System with Automated Delivery, Measurement, and Management for Pills.
Vivera picks up new patent for electronic dose-controlled drug delivery devices Newport Beach, California–based Vivera’s latest patent from the U.S. Patent and Trademark Office (USPTO) secures ZICOH’s rights as a smart dosing system with automated delivery, measurement, and management for oral format medications, including pills, capsules and tablets.
Vivera gets US patents for ZICOH smart inhaler Within one week in August, Vivera Pharmaceuticals has announced the issuance of two US patents covering its ZICOH’s smart inhaler technology. The first is US Patent No. 11,083,850 (“Secure smart dosing system with automated delivery, measurement, and management”) and the second is US Patent No. 11,090,449 (“Smart inhaler device with automated dose delivery, measurement, and management”).
Vivera Pharmaceuticals receives US patent for ZICOH Vivera Pharmaceuticals has announced that the US Patent and Trademark Office (USPTO) issued the US Patent No. 11,083,850 for ZICOH, the company’s wireless, electronic and dose-controlled medication-delivery device, according to a company statement.